Low Incidence of Off-Target Mutations in Individual CRISPR-Cas9 and TALEN Targeted Human Stem Cell Clones Detected by Whole-Genome Sequencing

Veres, Adrian, Gosis, Bridget S., Ding, Qiurong, Collins, Ryan, Ragavendran, Ashok, Brand, Harrison, Erdin, Serkan, Cowan, Chad A. +2 more·2014·Cell Stem Cell
DOI 10.1016/j.stem.2014.04.020

Cited by (474)

Items 201–300 of 474

  1. Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering
    Eric K. N. Gähwiler, Sarah E. Motta, Marcy Martin, Bramasta Nugraha, Simon Philipp Hoerstrup, Maximilian Y. Emmert · 2021 · Frontiers in Cell and Developmental Biology
  2. Recent Advancements in DNA Damage–Transcription Crosstalk and High-Resolution Mapping of DNA Breaks
    Valerio Vitelli, Alessandro Galbiati, Fabio Iannelli, Fabio Pessina, Sheetal Sharma, Fabrizio d’Adda di Fagagna · 2017 · Annual Review of Genomics and Human Genetics
  3. Induced Pluripotent Stem Cell Models to Enable In Vitro Models for Screening in the Central Nervous System
    Joshua G. Hunsberger, Anastasia G. Efthymiou, Nasir Malik, Mamta Behl, Ivy Mead, Xianmin Zeng, Anton M. Simeonov, Mahendra S. Rao · 2015 · Stem Cells and Development
  4. Genome Editing
    Kiran Musunuru · 2017 · Journal of the American College of Cardiology
  5. Modeling genetic epilepsies in a dish
    Wei Niu, Jack M. Parent · 2019 · Developmental Dynamics
  6. Inherited cardiac diseases, pluripotent stem cells, and genome editing combined—the past, present, and future
    Lettine van den Brink, Catarina Grandela, Christine L. Mummery, Richard P. Davis · 2019 · Stem Cells
  7. Induced Pluripotent Stem Cells in Huntington’s Disease Research: Progress and Opportunity
    Adelaide R. Tousley, Kimberly B. Kegel-Gleason · 2016 · Journal of Huntington s Disease
  8. Organoids as a Model for Colorectal Cancer
    Madeleine A. Young, Karen R. Reed · 2016 · Current Colorectal Cancer Reports
  9. Exome sequencing in the knockin mice generated using the CRISPR/Cas system
    Kazuo Nakajima, An‐a Kazuno, John R. Kelsoe, Moe Nakanishi, Toru Takumi, Tadafumi Kato · 2016 · Scientific Reports
  10. CRISPR/Cas9 Gene editing of RyR2 in human stem cell-derived cardiomyocytes provides a novel approach in investigating dysfunctional Ca2+ signaling
    Hua Wei, Xiaohua Zhang, Cassandra L. Clift, Naohiro Yamaguchi, Martin Morad · 2018 · Cell Calcium
  11. Patient-derived induced pluripotent stem cells for modelling genetic retinal dystrophies
    Leah P. Foltz, Dennis Clegg · 2018 · Progress in Retinal and Eye Research
  12. Gene therapy and genome editing for primary immunodeficiency diseases
    Zhiyong Zhang, Adrian James Thrasher, Fang Zhang · 2019 · Genes & Diseases
  13. Trio deep-sequencing does not reveal unexpected off-target and on-target mutations in Cas9-edited rhesus monkeys
    Xin Luo, Yaoxi He, Chao Zhang, Xiechao He, Lanzhen Yan, Min Li, Ting Hu, Yan Hu, Jin Jiang, Xiaoyu Meng et al. · 2019 · Nature Communications
  14. Immune Editing: Overcoming Immune Barriers in Stem Cell Transplantation
    Torsten B Meissner, Henrike S. Schulze, Stanley M. Dale · 2022 · Current Stem Cell Reports
  15. High-Throughput Silencing Using the CRISPR-Cas9 System: A Review of the Benefits and Challenges
    Mark R. Wade · 2015 · SLAS DISCOVERY
  16. Genome-edited human pluripotent stem cell–derived macrophages as a model of reverse cholesterol transport—brief report
    Gupta, Rajat M., Meissner, Torsten B., Cowan, Chad A., Musunuru, Kiran · 2016 · Arteriosclerosis, Thrombosis, and Vascular Biology
  17. Novel HDAd/EBV Reprogramming Vector and Highly Efficient Ad/CRISPR-Cas Sickle Cell Disease Gene Correction
    Chao Li, Lei Ding, Chiao‐Wang Sun, Li-Chen Wu, Dewang Zhou, Kevin M. Pawlik, Alireza Khodadadi‐Jamayran, Erik R. Westin, Frederick D. Goldman, Tim M. Townes · 2016 · Scientific Reports
  18. CRISPR ‐Cas9 technology and its application in haematological disorders
    Han Zhang, Nami McCarty · 2016 · British Journal of Haematology
  19. Nicotinic Acetylcholine Receptor Subtype Alpha-9 Mediates Triple-Negative Breast Cancers Based on a Spontaneous Pulmonary Metastasis Mouse Model
    Li‐Chi Huang, Ching‐Ling Lin, Jia-Zheng Qiu, Chun‐Yu Lin, Kai‐Wen Hsu, Ka‐Wai Tam, Jung-Yu Lee, Jinn‐Moon Yang, Chia‐Hwa Lee · 2017 · Frontiers in Cellular Neuroscience
  20. No off-target mutations in functional genome regions of a CRISPR/Cas9-generated monkey model of muscular dystrophy
    Shuang Wang, Shuaiwei Ren, Raoxian Bai, Puhao Xiao, Zhou Qin, Yin Zhou, Zhigang Zhou, Yuyu Niu, Weizhi Ji, Yongchang Chen · 2018 · Journal of Biological Chemistry
  21. Organoids: Past Learning and Future Directions
    Lauren O’Connell, Des C. Winter · 2019 · Stem Cells and Development
  22. Human Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies
    Michael W. Nestor, André W. Phillips, Elena Artimovich, Jonathan E. Nestor, John P. Hussman, Gene J. Blatt · 2015 · Autism Research
  23. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Jessica Taylor, Simon A. Woodcock · 2015 · SLAS DISCOVERY
  24. Non-SMC Element 2 (NSMCE2) of the SMC5/6 Complex Helps to Resolve Topological Stress
    Dideke E. Verver, Yi Zheng, Dave Speijer, Ron A. Hoebe, Henk L. Dekker, Sjoerd Repping, Jan Stap, Geert Hamer · 2016 · International Journal of Molecular Sciences
  25. CRISPR Genome Engineering for Human Pluripotent Stem Cell Research
    Somali Chaterji, Eun Hyun Ahn, Deok‐Ho Kim · 2017 · Theranostics
  26. Functional interrogation of Lynch syndrome‐associated MSH2 missense variants via CRISPR‐Cas9 gene editing in human embryonic stem cells
    Abhijit Rath, Akriti Mishra, Victoria Duque Ferreira, Chaoran Hu, Gregory Omerza, Kevin Kelly, Andrew Hesse, Honey V. Reddi, James P. Grady, Christopher D. Heinen · 2019 · Human Mutation
  27. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease
    Ilakya Selvarajan, Anu Toropainen, Kristina M. Garske, Maykel López Rodríguez, Arthur Ko, Zong Miao, Dorota Kamińska, Kadri Õunap, Tiit Örd, Aarthi Ravindran et al. · 2021 · The American Journal of Human Genetics
  28. Response to “Unexpected mutations after CRISPR–Cas9 editing in vivo”
    Caleb A. Lareau, Kendell Clement, Jonathan Y. Hsu, Vikram Pattanayak, J. Keith Joung, Martin J. Aryee, Luca Pinello · 2018 · Nature Methods
  29. Generation of highly enriched V2a interneurons from mouse embryonic stem cells
    Nisha R. Iyer, James E. Huettner, Jessica C. Butts, Chelsea R. Brown, Shelly E. Sakiyama‐Elbert · 2016 · Experimental Neurology
  30. Trio-Based Deep Sequencing Reveals a Low Incidence of Off-Target Mutations in the Offspring of Genetically Edited Goats
    Chao Li, Shiwei Zhou, Yan Li, Guanwei Li, Yige Ding, Lan Li, Jing Liu, Lei Qu, Tad Stewart Sonstegard, Xingxu Huang et al. · 2018 · Frontiers in Genetics
  31. Response to “Unexpected mutations after CRISPR–Cas9 editing in vivo”
    Sang‐Tae Kim, Jeongbin Park, Daesik Kim, Kyoungmi Kim, Sangsu Bae, Matthias Schlesner, Jin‐Soo Kim · 2018 · Nature Methods
  32. Efficient Genome Editing in Chicken DF-1 Cells Using the CRISPR/Cas9 System
    Yichun Bai, Linjie He, Pengcheng Li, Kun Xu, Simin Shao, Chonghua Ren, Zhongtian Liu, Zehui Wei, Zhiying Zhang · 2016 · G3 Genes Genomes Genetics
  33. CRISPR-Cas9: A Revolutionary Tool for Cancer Modelling
    Raúl Torres-Ruiz, Sandra Rodríguez · 2015 · International Journal of Molecular Sciences
  34. Shortening trinucleotide repeats using highly specific endonucleases: a possible approach to gene therapy?
    Guy‐Franck Richard · 2015 · Trends in Genetics
  35. Modeling developmental neuropsychiatric disorders with iPSC technology: challenges and opportunities
    Tracy L. Young‐Pearse, Eric M. Morrow · 2015 · Current Opinion in Neurobiology
  36. PC1/3 Deficiency Impacts Pro-opiomelanocortin Processing in Human Embryonic Stem Cell-Derived Hypothalamic Neurons
    Liheng Wang, Lina Sui, Sunil K. Panigrahi, Kana Meece, Yurong Xin, Jinrang Kim, Jesper Gromada, Claudia A. Doege, Sharon L. Wardlaw, Dieter M. Egli et al. · 2017 · Stem Cell Reports
  37. ssODN-Mediated In-Frame Deletion with CRISPR/Cas9 Restores FVIII Function in Hemophilia A-Patient-Derived iPSCs and ECs
    Zhiqing Hu, Miaojin Zhou, Yong Chao Wu, Zhuo Li, Xionghao Liu, Lingqian Wu, Desheng Liang · 2019 · Molecular Therapy — Nucleic Acids
  38. The Off-Targets of Clustered Regularly Interspaced Short Palindromic Repeats Gene Editing
    Manuel M. Vicente, Miguel Chaves‐Ferreira, João M. P. Jorge, João T. Proença, Vasco M. Barreto · 2021 · Frontiers in Cell and Developmental Biology
  39. Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers
    So Gun Hong, Ravi Chandra Yada, Kyujoo Choi, Arnaud Carpentier, T. Jake Liang, Randall K. Merling, Colin L. Sweeney, Harry L. Malech, Moonjung Jung, Marcus Alexandre Finzi Corat et al. · 2017 · Molecular Therapy
  40. Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in β-Thalassemia Induced Pluripotent Stem Cells (iPSCs)
    Ning Ma, Yongli Shan, Baojian Liao, Guanyi Kong, Cheng Wang, Ke Huang, Hui Zhang, Xiujuan Cai, Shubin Chen, Duanqing Pei et al. · 2015 · Journal of Biological Chemistry
  41. An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue
    Jiankang Jin, Yan Xu, Longfei Huo, Lang Ma, Ailing W. Scott, Melissa Pool Pizzi, Yuan Li, Ying Wang, Xiaodan Yao, Shumei Song et al. · 2020 · PLoS ONE
  42. The Rise of CRISPR/Cas for Genome Editing in Stem Cells
    Bing Shui, Liz Hernández-Matías, Yi Guo, Ying Peng · 2016 · Stem Cells International
  43. Efficient generation of P53 biallelic knockout Diannan miniature pigs via TALENs and somatic cell nuclear transfer
    Youfeng Shen, Kaixiang Xu, Zaimei Yuan, Jianxiong Guo, Heng Zhao, Xuezeng Zhang, Lu Zhao, Yubo Qing, Honghui Li, Weirong Pan et al. · 2017 · Journal of Translational Medicine
  44. Medical applications of clustered regularly interspaced short palindromic repeats (CRISPR/Cas) tool: A comprehensive overview
    Rodrigo Pinheiro Araldi, Charbel Khalil, Pedro Henrique Grignet, Michelli Ramires Teixeira, Thatiana Corrêa de Melo, Diego Grando Módolo, Luis G. V. Fernandes, Jorge Luis María Ruiz, Edislane Barreiros de Souza · 2020 · Gene
  45. Targeted genome engineering using designer nucleases: State of the art and practical guidance for application in human pluripotent stem cells.
    S. Merkert, U. Martin · 2016 · Stem Cell Research
  46. CRISPR Craze to Transform Cardiac Biology
    Sebastiaan J. van Kampen, Eva van Rooij · 2019 · Trends in Molecular Medicine
  47. A risk-based approach for cell line development, manufacturing and characterization of genetically engineered, induced pluripotent stem cell–derived allogeneic cell therapies
    Jennifer L. Dashnau, Qiong Xue, Monica Nelson, Eric Law, Lan Cao, Derek J. Hei · 2022 · Cytotherapy
  48. Efficient CRISPR-rAAV engineering of endogenous genes to study protein function by allele-specific RNAi
    Manuel Kaulich, Yeon J. Lee, Peter Lönn, Aaron D. Springer, Bryan R. Meade, Steven F. Dowdy · 2015 · Nucleic Acids Research
  49. Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”
    Dmitry S. Karpov, Anastasiia O. Sosnovtseva, Svetlana V. Pylina, Asya Bastrich, Darya A. Petrova, Maxim A. Kovalev, Anastasija I. Shuvalova, Еремкина Анна Константиновна, Natalia G. Mokrysheva · 2023 · International Journal of Molecular Sciences
  50. Assessment of genomic changes in a CRISPR/Cas9 Phaeodactylum tricornutum mutant through whole genome resequencing
    Monia Teresa Russo, Riccardo Aiese Cigliano, Walter Sanseverino, Maria Immacolata Ferrante · 2018 · PeerJ
  51. Response to “Unexpected mutations after CRISPR–Cas9 editing in vivo”
    Christopher J. Wilson, Tim J. Fennell, Anne Bothmer, Morgan L. Maeder, Deepak Reyon, Cecilia Cotta‐Ramusino, Cecilia A. Fernández, Eugenio Marco, Luis Alberto Barrera, Hariharan Jayaram et al. · 2018 · Nature Methods
  52. Altered (neo-) lacto series glycolipid biosynthesis impairs α2-6 sialylation on N-glycoproteins in ovarian cancer cells
    Shahidul Alam, Merrina Anugraham, Yen‐Lin Huang, Reto S. Kohler, Timm Hettich, Katharina Winkelbach, Yasmin Grether, Mónica Núñez López, Nailia R. Khasbiullina, Nicolai Vladimirovich Bovin et al. · 2017 · Scientific Reports
  53. Biosafety considerations triggered by genome-editing technologies
    Xinxin Li, Yuanjiao Gao, Ziyu Zhang, Wen Deng, Weihua Cao, Xin Chuan Wei, Zixuan Gao, Linmei Yao, Shuojie Wang, Yao Xie et al. · 2025 · Biosafety and Health
  54. Genome-Wide Analysis of Off-Target CRISPR/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones
    Richard H. Smith, Yun-Ching Chen, Fayaz Seifuddin, Daniel N. Hupalo, Camille Alba, Robert N. Reger, Xin Tian, Daisuke Araki, Clifton L. Dalgard, Richard W. Childs et al. · 2020 · Genes
  55. Concise Review: Fluorescent Reporters in Human Pluripotent Stem Cells: Contributions to Cardiac Differentiation and Their Applications in Cardiac Disease and Toxicity
    Sabine C. Den Hartogh, R. C. Passier · 2015 · Stem Cells
  56. Dissecting diabetes/metabolic disease mechanisms using pluripotent stem cells and genome editing tools
    Adrian Kee Keong Teo, Manoj K. Gupta, Alessandro Doria, Rohit Kulkarni · 2015 · Molecular Metabolism
  57. Gene Therapy, A Potential Therapeutic Tool for Neurological and Neuropsychiatric Disorders: Applications, Challenges and Future Perspective
    Shalini Mani, Divya Jindal, Manisha Singh · 2022 · Current Gene Therapy
  58. Combining CRISPR/Cas9 and rAAV Templates for Efficient Gene Editing
    Manuel Kaulich, Steven F. Dowdy · 2015 · Nucleic Acid Therapeutics
  59. Efficient gene targeting in mouse zygotes mediated by CRISPR/Cas9-protein
    Chris Jung, Junli Zhang, Elizabeth Trenchard, K. C. Kent Lloyd, David B. West, Barry P. Rosen, Pieter J. de Jong · 2016 · Transgenic Research
  60. Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival
    Deep Hathi, Chantiya Chanswangphuwana, Nicholas Cho, Francesca Fontana, Dolonchampa Maji, Julie Ritchey, Julie O’Neal, Anchal Ghai, Kathleen Duncan, Walter John Akers et al. · 2022 · Scientific Reports
  61. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling
    Zhixing Hu, Jiali Pu, Houbo Jiang, Ping Zhong, Jingxin Qiu, Feng Li, Xiaomin Wang, Baorong Zhang, Zhen Yan, Jian Feng · 2015 · Stem Cells and Development
  62. CRISPR/Cas-Mediated Knockin in Human Pluripotent Stem Cells
    Nipun Verma, Zeng‐Rong Zhu, Danwei Huangfu · 2016 · Methods in molecular biology
  63. CRISPR/Cas9-Mediated Genome Editing for Huntington’s Disease
    Gabriel Vachey, Nicole Déglon · 2018 · Methods in molecular biology
  64. A pre-screening FISH-based method to detect CRISPR/Cas9 off-targets in mouse embryonic stem cells
    Marianna Paulis, Alessandra Castelli, Michela Lizier, Lucia Susani, Franco Lucchini, ANNA MARIA VILLA, Paolo Vezzoni · 2015 · Scientific Reports
  65. CRISPR/Cas9-mediated genome editing in human stem cell-derived cardiomyocytes: Applications for cardiovascular disease modelling and cardiotoxicity screening
    Effimia Christidi, Haojun Huang, Liam R. Brunham · 2018 · Drug Discovery Today Technologies
  66. Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling
    Yonggang Zhang, Gustavo Arango, Fang Li, Xiao Xiao, Raj Putatunda, Jun Yu, Xiao Feng Yang, Hong Wang, Layne T. Watson, Liqing Zhang et al. · 2018 · BMC Medical Genomics
  67. Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification
    Jiali Pu, David Frescas, Baorong Zhang, Jian Feng · 2015 · Experimental Biology and Medicine
  68. What’s Changed with Genome Editing?
    Shengdar Q. Tsai, J. Keith Joung · 2014 · Cell stem cell
  69. Progress and Prospects of Gene Editing in Pluripotent Stem Cells
    Zhenwu Zhang, Xinyu Bao, Chao‐Po Lin · 2023 · Biomedicines
  70. Efficient generation of GGTA1-null Diannan miniature pigs using TALENs combined with somatic cell nuclear transfer
    Wenmin Cheng, Heng Zhao, Honghao Yu, Jige Xin, Jia Wang, Luyao Zeng, Zaimei Yuan, Yubo Qing, Honghui Li, Baoyu Jia et al. · 2016 · Reproductive Biology and Endocrinology
  71. The Therapeutic Potential of CRISPR/Cas9 Systems in Oncogene-Addicted Cancer Types: Virally Driven Cancers as a Model System
    Luqman Jubair, Nigel A.J. McMillan · 2017 · Molecular Therapy — Nucleic Acids
  72. The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
    Caroline F. Peddle, Robert Edward MacLaren · 2017 · PubMed Central
  73. Off-target genome editing: A new discipline of gene science and a new class of medicine
    Diane Catherine Wang, Xiangdong Wang · 2019 · Cell Biology and Toxicology
  74. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish
    Federico Gonzãlez · 2016 · Developmental Dynamics
  75. Protocol for the Generation of Human Pluripotent Reporter Cell Lines Using CRISPR/Cas9
    Aaron Zhong, Mu Li, Ting Zhou · 2020 · STAR Protocols
  76. Engineered yeast genomes accurately assembled from pure and mixed samples
    Joseph H. Collins, Kevin W. Keating, Trent R. Jones, Shravani Balaji, Celeste B. Marsan, Marina Çomo, Zachary J. Newlon, Tom Mitchell, Bryan Bartley, Aaron Adler et al. · 2021 · Nature Communications
  77. Genome-wide specificity of plant genome editing by both CRISPR–Cas9 and TALEN
    Nadia Bessoltane, Florence Charlot, Anouchka Guyon‐Debast, Delphine Charif, Kostlend Mara, Cécile Collonnier, Pierre‐François Perroud, Mark Tepfer, Fabien Nogué · 2022 · Scientific Reports
  78. Genetic engineering and genome editing in plants, animals and humans: Facts and myths
    Maria Platani, Owolabi Emmanuel Sokefun, Elias Bassil, Yiorgos Apidianakis · 2022 · Gene
  79. Eliminate mitochondrial diseases by gene editing in germ-line cells and embryos
    Si Wang, Fei Yi, Jing Tao Qu · 2015 · Protein & Cell
  80. Genome Editing Gene Therapy for Duchenne Muscular Dystrophy
    A. Hotta · 2015 · Journal of Neuromuscular Diseases
  81. Genome engineering tools for building cellular models of disease
    Jennie J. Lin, Kiran Musunuru · 2016 · FEBS Journal
  82. Proven and novel strategies for efficient editing of the human genome
    Claudio Mussolino, Tafadzwa Mlambo, Toni Cathomen · 2015 · Current Opinion in Pharmacology
  83. Investigating Leber's hereditary optic neuropathy: Cell models and future perspectives
    Elona Jankauskaitė, Ewa Bartnik, Agata Kodroń · 2016 · Mitochondrion
  84. Genome editing-based HIV therapies
    Wan-Gang Gu · 2015 · Trends in biotechnology
  85. Engineering T Cells Using CRISPR/Cas9 for Cancer Therapy
    Xingying Zhang, Chen Cheng, Wen Ce Sun, Haoyi Wang · 2020 · Methods in molecular biology
  86. The Application of CRISPR-Cas9 Genome Editing in Caenorhabditis elegans
    Suhong Xu · 2015 · Journal of genetics and genomics/Journal of Genetics and Genomics
  87. Genome editing in the butterfly type‐species Papilio machaon
    Xueyan Li, Gui‐Chun Liu, Wen‐Jing Sheng, Zhiwei Dong, Lei Chen, Ruo‐Ping Zhao, Wen Wang · 2016 · Insect Science
  88. A history of genome editing in Saccharomyces cerevisiae
    William G. Alexander · 2017 · Yeast
  89. Determining the Biological Mechanisms of Action for Environmental Exposures: Applying CRISPR/Cas9 to Toxicological Assessments
    Henry Lujan, Eric J. Romer, Richard L. Salisbury, Saber M. Hussain, Christie Maria Sayes · 2020 · Toxicological Sciences
  90. Application of genome editing technologies to the study and treatment of hematological disease
    Andrea Pellagatti, Hamid Dolatshad, Bon Ham Yip, Simona Valletta, Jacqueline Boultwood · 2015 · Advances in Biological Regulation
  91. CRISPR/Cas9‐based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells
    Navin R. Gupta, Koichiro Susa, Yoko Yoda, Joseph Vincent Bonventre, M. Todd Valerius, Ryuji Morizane · 2018 · Current Protocols in Stem Cell Biology
  92. Data Mining by Pluralistic Approach on CRISPR Gene Editing in Plants
    Tanushri Kaul, Nitya Meenakshi Raman, Murugesh Eswaran, Arulprakash Thangaraj, Rachana Verma, Sonia Khan Sony, Krishnamurthy Sathelly, Rashmi Kaul, Pranjal Yadava, Pawan Kumar Agrawal · 2019 · Frontiers in Plant Science
  93. Genome-wide detection and analysis of CRISPR-Cas off-targets
    Tomás Rodríguez, Sina Dadafarin, Henry Pratt, Pengpeng Liu, Nadia Amrani, Lihua Julie Zhu · 2021 · Progress in molecular biology and translational science
  94. Genome engineering of isogenic human ES cells to model autism disorders
    Refugio A. Martinez, Jason L. Stein, Anne-Rachel Krostag, Angelique M. Nelson, John Marken, Vilas Menon, Ryan May, Zizhen Yao, Ajamete Kaykas, Daniel H. Geschwind et al. · 2015 · Nucleic Acids Research
  95. Doxycycline inducible overexpression systems: how to induce your gene of interest without inducing misinterpretations
    Jolan De Boeck, Catherine M. Verfaillie · 2021 · Molecular Biology of the Cell
  96. Transcriptional landscape of a RET C634Y -mutated iPSC and its CRISPR-corrected isogenic control reveals the putative role of EGR1 transcriptional program in the development of multiple endocrine neoplasia type 2A-associated cancers
    Julien Hadoux, Christophe Desterke, Olivier Féraud, Mathieu Guibert, Roberta Francesca De Rose, Paule Opolon, Dominique Divers, Emilie Gobbo, Frank Griscelli, Martin Jean Schlumberger et al. · 2017 · Stem Cell Research
  97. Current and Future Methodology for Quantitation and Site-Specific Mapping the Location of DNA Adducts
    Gunnar Boysen, Intawat Nookaew · 2022 · Toxics
  98. Low-Dose Irradiation Enhances Gene Targeting in Human Pluripotent Stem Cells
    Seigo Hatada, Aparna Subramanian, Berhan Mandefro, Songyang Ren, Ho Won Kim, Jie Tang, Vincent Anthony Funari, Robert H. Baloh, Dhruv Sareen, Vaithilingaraja Arumugaswami et al. · 2015 · Stem Cells Translational Medicine
  99. Comprehensive analysis of off-target and on-target effects resulting from liver-directed CRISPR-Cas9-mediated gene targeting with AAV vectors
    Kshitiz Singh, Raffaele Fronza, Hanneke Evens, Marinee Chuah, Thierry VandenDriessche · 2024 · Molecular Therapy — Methods & Clinical Development
  100. Gene Editing of the Catfish Gonadotropin-Releasing Hormone Gene and Hormone Therapy to Control the Reproduction in Channel Catfish, Ictalurus punctatus
    Guyu Tracy Qin, Zhenkui Qin, Cuiyu Lu, Zhi Ye, Ahmed Elaswad, Max R. Bangs, Hanbo Li, Yiliu Zhang, Yingqi Huang, Huitong Shi et al. · 2022 · Biology